Povi Dental Care

Description

The drug is identified by SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the oral rinse use in adults and children aged 6 years and older. It is to be used twice daily after brushing teeth with toothpaste. Patients should vigorously swish 10 milliliters of the rinse between their teeth for 1 minute and then spit it out. It is important that the rinse is not swallowed, and patients should refrain from eating or drinking for 30 minutes following the rinse.

For children under 12 years of age, it is recommended that caregivers instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision is advised until the child is capable of using the product without assistance. For children under 6 years of age, consultation with a dentist or doctor is necessary prior to use.

No teratogenic or nonteratogenic effects have been reported with this drug.

Dosage and Administration

The product is indicated for dental use only. Healthcare professionals should ensure that the administration is confined to the oral cavity and that appropriate techniques are employed to minimize the risk of systemic exposure.

Dosing should be tailored to the individual patient's needs, taking into account the specific dental procedure being performed. It is essential to follow established guidelines for dosage ranges and intervals as per the clinical context.

Preparation of the product should be conducted in accordance with standard aseptic techniques to maintain sterility and efficacy. The method of administration should be executed with precision to ensure optimal therapeutic outcomes while minimizing discomfort to the patient.

Healthcare professionals are advised to monitor the patient for any adverse reactions during and after the administration, adjusting the dosage as necessary based on the patient's response and clinical judgment.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no identified risks of abuse, misuse, or dependence.

Warnings and Precautions

The use of this product requires adherence to specific warnings and precautions to ensure safety and efficacy.

Usage Guidelines This product is intended solely for use as a mouthwash. It is imperative that it not be swallowed. In the event of accidental ingestion of a large quantity, immediate consultation with a healthcare professional is advised. Additionally, it should not be administered to another patient to prevent cross-contamination.

Pediatric Use When considering the use of this product in children, it must be done under the guidance and supervision of a guardian. Special caution is warranted for children under 6 years of age; use in this population should only occur with explicit instructions from a pharmacist or physician.

Storage and Handling To maintain product integrity, it should be stored away from direct sunlight and kept as cool as possible. It is essential to keep the product out of reach of children to prevent accidental ingestion. Furthermore, users should refrain from inserting any other containers into the product to ensure quality preservation.

Patient Considerations This product is contraindicated in patients with known iodine intolerance or thyroid dysfunction. Pregnant women, breastfeeding women, or those who may become pregnant should also exercise caution and consult a healthcare provider prior to use.

Regular monitoring and adherence to these guidelines are crucial for the safe use of this product.

Side Effects

Patients with iodine intolerance, thyroid dysfunction, and pregnant or breastfeeding women who may be pregnant or are pregnant should be closely monitored due to potential adverse reactions associated with the use of this medication. These populations may experience heightened sensitivity or complications, necessitating careful consideration before administration.

Clinical judgment is essential when prescribing this medication to these specific groups to mitigate risks and ensure patient safety.

Drug Interactions

Patients with iodine intolerance may experience interactions that could affect their treatment outcomes. It is advisable for these patients to discuss their specific circumstances with a healthcare provider to ensure safe medication use.

Additionally, individuals with thyroid dysfunction should be aware that their condition may lead to potential interactions with certain medications. Close monitoring and consultation with a healthcare professional are recommended to manage any risks associated with these interactions.

Pregnant women, as well as those who are breastfeeding or may become pregnant, should seek guidance from a healthcare provider regarding potential drug interactions. This precaution is essential to ensure both maternal and fetal safety during medication therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Povi Dental Care (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep this product out of reach of children. For children aged 6 years and older, the recommended usage is twice daily after brushing teeth with toothpaste. Patients should vigorously swish 10 milliliters of the rinse between their teeth for 1 minute and then spit it out, ensuring that they do not swallow the rinse. It is advised that they refrain from eating or drinking for 30 minutes following the rinse.

For children under 12 years of age, it is important to instruct them in proper rinsing techniques to minimize the risk of swallowing the product. Supervision may be necessary until the child is capable of using the rinse without assistance.

Children under 6 years of age should not use this product without prior consultation with a dentist or doctor. The use of this product in this age group should always be under the guidance and supervision of a guardian, and it is essential that pharmacists or doctors provide instructions before use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant women or breastfeeding women who may be pregnant should not use this product. The potential risks associated with the use of this product during pregnancy have not been established, and its safety in this population remains unclear. Healthcare professionals are advised to counsel women of childbearing potential regarding the importance of avoiding this product during pregnancy and while breastfeeding.

Lactation

Lactating mothers should consult a doctor before using this medication if they are breastfeeding or may become pregnant. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals are advised to consider the potential risks and benefits when recommending this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative for healthcare professionals to act promptly. If a patient has ingested a significant quantity of the medication, immediate consultation with a physician is essential.

Potential symptoms of overdosage may vary depending on the specific medication involved; however, it is crucial to monitor the patient closely for any adverse effects.

Management of overdosage should be guided by the severity of symptoms and the specific pharmacological properties of the drug. Healthcare providers are advised to follow established protocols for the management of overdose, which may include supportive care and symptomatic treatment as necessary.

In all cases of suspected overdosage, the involvement of a poison control center or toxicology expert may be beneficial to ensure appropriate management and intervention.

Nonclinical Toxicology

Pregnant women or breastfeeding women who may be pregnant or are pregnant should be considered in the context of teratogenic effects. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important for patients to understand the potential risks associated with improper access to the medication by young children.

Storage and Handling

The product is supplied in configurations that ensure optimal quality and efficacy. It is essential to avoid direct sunlight and maintain a cool environment during storage. To preserve the integrity of the product, it is crucial not to insert it into any other containers. Proper handling and adherence to these storage conditions will help ensure the product remains effective for its intended use.

Additional Clinical Information

The product is administered orally, with specific instructions for adults and children aged 6 years and older to use it twice daily after brushing their teeth. Patients should vigorously swish 10 milliliters of the rinse between their teeth for one minute before spitting it out, ensuring not to swallow the rinse. It is advised that patients refrain from eating or drinking for 30 minutes post-rinsing. For children under 12, guardians should supervise the rinsing process to minimize the risk of swallowing, and consultation with a dentist or doctor is recommended for children under 6 years of age.

Clinicians should counsel patients on the importance of not swallowing the product and using it solely as a mouthwash. It is crucial to keep the product out of reach of children and to avoid exposure to direct sunlight, storing it in a cool environment. Patients should not transfer the rinse to other containers to maintain quality and should not administer it to others. If a large amount is swallowed, immediate consultation with a healthcare provider is necessary.

Drug Information (PDF)

This file contains official product information for Povi Dental Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)